Fungal spores: hazardous to health? (2024)

  • Journal List
  • Environ Health Perspect
  • v.107(Suppl 3); 1999 Jun
  • PMC1566211

As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsem*nt of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice

Fungal spores: hazardous to health? (1)

Link to Publisher's site

Abstract

Fungi have long been known to affect human well being in various ways, including disease of essential crop plants, decay of stored foods with possible concomitant production of mycotoxins, superficial and systemic infection of human tissues, and disease associated with immune stimulation such as hypersensitivity pneumonitis and toxic pneumonitis. The spores of a large number of important fungi are less than 5 microm aerodynamic diameter, and therefore are able to enter the lungs. They also may contain significant amounts of mycotoxins. Diseases associated with inhalation of fungal spores include toxic pneumonitis, hypersensitivity pneumonitis, tremors, chronic fatigue syndrome, kidney failure, and cancer.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (863K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

469
470
471
472

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  • Brunekreef B, Dockery DW, Speizer FE, Ware JH, Spengler JD, Ferris BG. Home dampness and respiratory morbidity in children. Am Rev Respir Dis. 1989 Nov;140(5):1363–1367. [PubMed] [Google Scholar]
  • Dales RE, Zwanenburg H, Burnett R, Franklin CA. Respiratory health effects of home dampness and molds among Canadian children. Am J Epidemiol. 1991 Jul 15;134(2):196–203. [PubMed] [Google Scholar]
  • Dales RE, Miller D, McMullen E. Indoor air quality and health: validity and determinants of reported home dampness and moulds. Int J Epidemiol. 1997 Feb;26(1):120–125. [PubMed] [Google Scholar]
  • Spengler JD, Sexton K. Indoor air pollution: a public health perspective. Science. 1983 Jul 1;221(4605):9–17. [PubMed] [Google Scholar]
  • Samson RA. Mycotoxins: a mycologist's perspective. J Med Vet Mycol. 1992;30 (Suppl 1):9–18. [PubMed] [Google Scholar]
  • Jarvis BB, Salemme J, Morais A. Stachybotrys toxins. 1. Nat Toxins. 1995;3(1):10–16. [PubMed] [Google Scholar]
  • Hayes RB, van Nieuwenhuize JP, Raatgever JW, ten Kate FJ. Aflatoxin exposures in the industrial setting: an epidemiological study of mortality. Food Chem Toxicol. 1984 Jan;22(1):39–43. [PubMed] [Google Scholar]
  • Dvorácková I. Aflatoxin inhalation and alveolar cell carcinoma. Br Med J. 1976 Mar 20;1(6011):691–691. [PMC free article] [PubMed] [Google Scholar]
  • Olsen JH, Dragsted L, Autrup H. Cancer risk and occupational exposure to aflatoxins in Denmark. Br J Cancer. 1988 Sep;58(3):392–396. [PMC free article] [PubMed] [Google Scholar]
  • Deger GE. Letter: Aflatoxin--human colon carcinogenesis? Ann Intern Med. 1976 Aug;85(2):204–205. [PubMed] [Google Scholar]
  • Autrup JL, Schmidt J, Seremet T, Autrup H. Determination of exposure to aflatoxins among Danish workers in animal-feed production through the analysis of aflatoxin B1 adducts to serum albumin. Scand J Work Environ Health. 1991 Dec;17(6):436–440. [PubMed] [Google Scholar]
  • Zarba A, Hmieleski R, Hemenway DR, Jakab GJ, Groopman JD. Aflatoxin B1--DNA adduct formation in rat liver following exposure by aerosol inhalation. Carcinogenesis. 1992 Jun;13(6):1031–1033. [PubMed] [Google Scholar]
  • Jakab GJ, Hmieleski RR, Zarba A, Hemenway DR, Groopman JD. Respiratory aflatoxicosis: suppression of pulmonary and systemic host defenses in rats and mice. Toxicol Appl Pharmacol. 1994 Apr;125(2):198–205. [PubMed] [Google Scholar]
  • Andrássy K, Horváth I, Lakos T, Töke Z. Massenhaftes Auftreten von Mykotoxikosen im Komitat Hajdu-Bihar. Mykosen. 1980 Mar;23(3):130–133. [PubMed] [Google Scholar]
  • Kjellman B, Elinder G, Garwicz S, Svan H. Idiopathic pulmonary haemosiderosis in Swedish children. Acta Paediatr Scand. 1984 Sep;73(5):584–588. [PubMed] [Google Scholar]
  • Ohga S, Takahashi K, Miyazaki S, Kato H, Ueda K. Idiopathic pulmonary haemosiderosis in Japan: 39 possible cases from a survey questionnaire. Eur J Pediatr. 1995 Dec;154(12):994–995. [PubMed] [Google Scholar]
  • Etzel RA, Montaña E, Sorenson WG, Kullman GJ, Allan TM, Dearborn DG, Olson DR, Jarvis BB, Miller JD. Acute pulmonary hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med. 1998 Aug;152(8):757–762. [PubMed] [Google Scholar]
  • Jarvis BB, Sorenson WG, Hintikka EL, Nikulin M, Zhou Y, Jiang J, Wang S, Hinkley S, Etzel RA, Dearborn D. Study of toxin production by isolates of Stachybotrys chartarum and Memnoniella echinata isolated during a study of pulmonary hemosiderosis in infants. Appl Environ Microbiol. 1998 Oct;64(10):3620–3625. [PMC free article] [PubMed] [Google Scholar]
  • Nikulin M, Reijula K, Jarvis BB, Veijalainen P, Hintikka EL. Effects of intranasal exposure to spores of Stachybotrys atra in mice. Fundam Appl Toxicol. 1997 Feb;35(2):182–188. [PubMed] [Google Scholar]
  • Johanning E, Biagini R, Hull D, Morey P, Jarvis B, Landsbergis P. Health and immunology study following exposure to toxigenic fungi (Stachybotrys chartarum) in a water-damaged office environment. Int Arch Occup Environ Health. 1996;68(4):207–218. [PubMed] [Google Scholar]
  • Hodgson MJ, Morey P, Leung WY, Morrow L, Miller D, Jarvis BB, Robbins H, Halsey JF, Storey E. Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J Occup Environ Med. 1998 Mar;40(3):241–249. [PubMed] [Google Scholar]
  • Dill I, Trautmann C, Szewzyk R. Massenentwicklung von Stachybotrys chartarum auf kompostierbaren Pflanztöpfen aus Altpapier. Mycoses. 1997;40 (Suppl 1):110–114. [PubMed] [Google Scholar]
  • Di Paolo N, Guarnieri A, Loi F, Sacchi G, Mangiarotti AM, Di Paolo M. Acute renal failure from inhalation of mycotoxins. Nephron. 1993;64(4):621–625. [PubMed] [Google Scholar]
  • Gordon KE, Masotti RE, Waddell WR. Tremorgenic encephalopathy: a role of mycotoxins in the production of CNS disease in humans? Can J Neurol Sci. 1993 Aug;20(3):237–239. [PubMed] [Google Scholar]
  • Parker GF, Jenner PC. Distribution of trypacidin in cultures of Aspergillus fumigatus. Appl Microbiol. 1968 Aug;16(8):1251–1252. [PMC free article] [PubMed] [Google Scholar]
  • Palmgren MS, Lee LS. Separation of mycotoxin-containing sources in grain dust and determination of their mycotoxin potential. Environ Health Perspect. 1986 Apr;66:105–108. [PMC free article] [PubMed] [Google Scholar]
  • Wicklow DT, Shotwell OL. Intrafungal distribution of aflatoxins among conidia and sclerotia of Aspergillus flavus and Aspergillus parasiticus. Can J Microbiol. 1983 Jan;29(1):1–5. [PubMed] [Google Scholar]
  • Sorenson WG, Frazer DG, Jarvis BB, Simpson J, Robinson VA. Trichothecene mycotoxins in aerosolized conidia of Stachybotrys atra. Appl Environ Microbiol. 1987 Jun;53(6):1370–1375. [PMC free article] [PubMed] [Google Scholar]
  • Bauer J, Gareis M, Bott A, Gedek B. Isolation of a mycotoxin (gliotoxin) from a bovine udder infected with Aspergillus fumigatus. J Med Vet Mycol. 1989;27(1):45–50. [PubMed] [Google Scholar]
  • Shah DT, Larsen B. Clinical isolates of yeast produce a gliotoxin-like substance. Mycopathologia. 1991 Dec;116(3):203–208. [PubMed] [Google Scholar]
  • Land CJ, Sostarić B, Fuchs R, Lundström H, Hult K. Intratracheal exposure of rats to Aspergillus fumigatus spores isolated from sawmills in Sweden. Appl Environ Microbiol. 1989 Nov;55(11):2856–2860. [PMC free article] [PubMed] [Google Scholar]
  • Smith JE, Anderson JG, Lewis CW, Murad YM. Cytotoxic fungal spores in the indoor atmosphere of the damp domestic environment. FEMS Microbiol Lett. 1992 Dec 15;100(1-3):337–343. [PubMed] [Google Scholar]
  • Strachan DP, Sanders CH. Damp housing and childhood asthma; respiratory effects of indoor air temperature and relative humidity. J Epidemiol Community Health. 1989 Mar;43(1):7–14. [PMC free article] [PubMed] [Google Scholar]
  • Macgeorge KM, Mantle PG. Nephrotoxicity of Penicillium aurantiogriseum and P. commune from an endemic nephropathy area of Yugoslavia. Mycopathologia. 1990 Dec;112(3):139–145. [PubMed] [Google Scholar]
  • Gerberick GF, Sorenson WG. Toxicity of T-2 toxin, a Fusarium mycotoxin, to alveolar macrophages in vitro. Environ Res. 1983 Dec;32(2):269–285. [PubMed] [Google Scholar]
  • Gerberick GF, Sorenson WG, Lewis DM. The effects of T-2 toxin on alveolar macrophage function in vitro. Environ Res. 1984 Feb;33(1):246–260. [PubMed] [Google Scholar]
  • Sorenson WG, Simpson J, Castranova V. Toxicity of the mycotoxin patulin for rat alveolar macrophages. Environ Res. 1985 Dec;38(2):407–416. [PubMed] [Google Scholar]
  • Sorenson WG, Gerberick GF, Lewis DM, Castranova V. Toxicity of mycotoxins for the rat pulmonary macrophage in vitro. Environ Health Perspect. 1986 Apr;66:45–53. [PMC free article] [PubMed] [Google Scholar]
  • Ayral AM, Dubech N, Le Bars J, Escoula L. In vitro effect of diacetoxyscirpenol and deoxynivalenol on microbicidal activity of murine peritoneal macrophages. Mycopathologia. 1992 Nov;120(2):121–127. [PubMed] [Google Scholar]
  • Vidal D, Mavet S. In vitro and in vivo toxicity of T-2 toxin, a Fusarium mycotoxin, to mouse peritoneal macrophages. Infect Immun. 1989 Jul;57(7):2260–2264. [PMC free article] [PubMed] [Google Scholar]
  • Lafarge-Frayssinet C, Lespinats G, Lafont P, Loisillier F, Mousset S, Rosenstein Y, Frayssinet C. Immunosuppressive effects of Fusarium extracts and trichothecenes: blastogenic response of murine splenic and thymic cells to mitogens. Proc Soc Exp Biol Med. 1979 Mar;160(3):302–311. [PubMed] [Google Scholar]
  • Rosenstein Y, Lafarge-Frayssinet C, Lespinats G, Loisillier F, Lafont P, Frayssinet C. Immunosuppressive activity of Fusarium toxins. Effects on antibody synthesis and skin grafts of crude extracts, T2-toxin and diacetoxyscirpenol. Immunology. 1979 Jan;36(1):111–117. [PMC free article] [PubMed] [Google Scholar]
  • Eichner RD, Al Salami M, Wood PR, Müllbacher A. The effect of gliotoxin upon macrophage function. Int J Immunopharmacol. 1986;8(7):789–797. [PubMed] [Google Scholar]
  • Pestka JJ, Bondy GS. Alteration of immune function following dietary mycotoxin exposure. Can J Physiol Pharmacol. 1990 Jul;68(7):1009–1016. [PubMed] [Google Scholar]
  • Creasia DA, Thurman JD, Jones LJ, 3rd, Nealley ML, York CG, Wannemacher RW, Jr, Bunner DL. Acute inhalation toxicity of T-2 mycotoxin in mice. Fundam Appl Toxicol. 1987 Feb;8(2):230–235. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

Fungal spores: hazardous to health? (2024)

FAQs

Fungal spores: hazardous to health? ›

They also may contain significant amounts of mycotoxins. Diseases associated with inhalation of fungal spores include toxic pneumonitis, hypersensitivity pneumonitis, tremors, chronic fatigue syndrome, kidney failure, and cancer.

Can fungal spores infect humans? ›

Of the millions of fungal species, only a few can naturally infect humans. But medical advances have rendered more people—especially the immunocompromised—susceptible to infections with fungi not previously considered pathogenic. Fungal infections today are among the most difficult diseases to manage in humans.

Why should humans avoid breathing in fungal spores? ›

Most strains of this mold are harmless, but a few can cause serious illnesses when people with weakened immune systems, underlying lung disease or asthma inhale their fungal spores. In some people, the spores trigger an allergic reaction. Other people develop mild to serious lung infections.

What happens if you breathe in spores? ›

Inhaling or touching mold or mold spores may cause allergic reactions in sensitive individuals. Allergic responses include hay fever-type symptoms, such as sneezing, runny nose, red eyes, and skin rash (dermatitis). Allergic reactions to mold are common. They can be immediate or delayed.

What are the hazardous effects of fungi? ›

People who live or work in damp places where mold is present have a higher chance of developing respiratory diseases, skin irritation, and other health problems. There may also be a higher risk of cancer.

Can you get sick from fungal spores? ›

They also may contain significant amounts of mycotoxins. Diseases associated with inhalation of fungal spores include toxic pneumonitis, hypersensitivity pneumonitis, tremors, chronic fatigue syndrome, kidney failure, and cancer.

Can fungal spores be airborne? ›

Outdoor airborne fungal spores are associated with allergy. A systematic review of outdoor fungal seasonality in Europe was conducted. Allergenic spores of Alternaria and Cladosporium were the focus of most studies. Alternaria and Cladosporium seasons were longer in south-westerly regions.

What are the symptoms of inhaling fungal spores? ›

shortness of breath. a cough – you may cough up blood or lumps of mucus. wheezing. a high temperature.

Is it OK to breathe in mold spores? ›

Breathing mold can cause allergic and respiratory symptoms. It is hard to say how much mold will cause health problems as some people are more sensitive to mold than others: People with current respiratory conditions (e.g., allergies, asthma, or emphysema)

How do you get rid of mold spores in your lungs? ›

Antifungal medications.

These drugs are the standard treatment for invasive pulmonary aspergillosis. The most effective treatment is a newer antifungal drug, voriconazole (Vfend). Amphotericin B is another option.

What are 3 harmful diseases caused by fungi? ›

Fungal Disease-Specific Research
  • Candidiasis. Candida are yeast that can be found on the skin, mucous membranes, and in the intestinal tract. ...
  • Cryptococcosis. ...
  • Aspergillosis. ...
  • Coccidioidomycosis (Valley Fever) ...
  • Histoplasmosis. ...
  • Blastomycosis. ...
  • Pneumocystis pneumonia.
Sep 15, 2022

What are two examples of how fungi can harm humans? ›

In addition to rhinitis and asthma, exposure to fungi is associated with a number of other illnesses including allergic bronchopulmonary mycoses, allergic fungal sinusitis and hypersensitivity pneumonitis.

Is fungi a respiratory hazard? ›

Most of these are harmless, but some can cause respiratory and other disorders when workers inhale or come into contact with fungi. Inhalation is the route of exposure of most concern to flood cleanup workers.

Can fungal spores spread? ›

Spores are disseminated through environmental factors. Wind, water, or animal carriage allow spores to be spread ubiquitously throughout the environment. Spores will break dormancy and begin to germinate once exposed to favorable conditions.

What are the symptoms of fungal spore? ›

Health effects of fungal spores

These symptoms include sneezing, runny nose, mucous production, cough, congestion, sinusitis, earache, headache, wheezing, asthma and a range of bronchial symptoms and diseases.

Can fungus spread inside your body? ›

When fungal organisms enter the body and the immune system is compromised these fungi grow, spread and invade into tissue and spread locally. Some organisms, especially yeast and some molds, can invade the blood vessels and cause infection in the bloodstream and distant organs.

Top Articles
Latest Posts
Article information

Author: Patricia Veum II

Last Updated:

Views: 5619

Rating: 4.3 / 5 (44 voted)

Reviews: 83% of readers found this page helpful

Author information

Name: Patricia Veum II

Birthday: 1994-12-16

Address: 2064 Little Summit, Goldieton, MS 97651-0862

Phone: +6873952696715

Job: Principal Officer

Hobby: Rafting, Cabaret, Candle making, Jigsaw puzzles, Inline skating, Magic, Graffiti

Introduction: My name is Patricia Veum II, I am a vast, combative, smiling, famous, inexpensive, zealous, sparkling person who loves writing and wants to share my knowledge and understanding with you.